Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3
Clinical trial NCT04649229 · COMPLETED
Trial details
- NCT number
- NCT04649229
- Sponsor
- Yale University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-27
- Primary completion
- 2025-05-22
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.